UMIN ID: UMIN000007076
Registered date:16/01/2012
Rituximab treatment for patients with Wegener's granulomatosis
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Wegener's granulomatosis |
| Date of first enrollment | 2011/01/01 |
| Target sample size | 5 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Weekly infusion of rituximab 500 mg for 4 times |
Outcome(s)
| Primary Outcome | complete remission at 12 months |
|---|---|
| Secondary Outcome | adverse events, BVAS/WG |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | The case who is disqualified by the physician |
Related Information
| Primary Sponsor | Kawasaki Medical School |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Kawasaki Medical School |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yoshitaka Morita |
| Address | 577 Matushima, Kurashiki, Okayama, Japan Japan |
| Telephone | 086-462-1111 |
| morita@med.kawasaki-m.ac.jp | |
| Affiliation | Kawasaki Medical School Department of Rheumatology |
| scientific contact | |
| Name | Yoshitaka Morita |
| Address | 577 Matushima, Kurashiki, Okayama, Japan Japan |
| Telephone | 086-462-1111 |
| rheumatology@med.kawasaki-m.ac.jp | |
| Affiliation | Kawasaki Medical School Department of Rheumatology |